Use of Polygenic Risk Scores to Select Screening Intervals After Negative Findings From Colonoscopy
Affiliations
- PMID: 32376506
- DOI: 10.1016/j.cgh.2020.04.077
Abstract
Background & aims: Polygenic risk scores (PRSs) could help to define starting ages for colorectal cancer (CRC) screening. However, the role of PRS in determining the length of screening interval after negative findings from colonoscopies is unclear. We aimed to evaluate colorectal cancer (CRC) risk according to PRS and time since last negative colonoscopy.
Methods: We collected data from 3827 cases and 2641 CRC-free controls in a population-based case-control study in Germany. We constructed a polygenic risk scoring system, based on 90 single-nucleotide polymorphisms, associated with risk of CRC in people of European descent. Participants were classified as having low, medium, or high genetic risk according to tertiles of PRSs among controls. Multiple logistic regression models were used to assess CRC risk according to PRS and time since last negative colonoscopy.
Results: Compared to individuals without colonoscopy in the low PRS category, a 42%-85% lower risk of CRC was observed for individuals who had a negative finding from colonoscopy within 10 years. Beyond 10 years after a negative finding from colonoscopy, significantly lower risk only persisted for the low and medium PRS groups, but not for the high PRS group. Adjusted odds ratios were 0.44 (95% CI, 0.29-0.68), 0.51 (95% CI, 0.34-0.77), and 0.85 (95% CI, 0.58-1.23) in the low, medium, and high PRS group, respectively. Within any time interval, risks were lower for distal than for proximal CRCs.
Conclusion: Based on findings from a population-based case-control study, the recommended 10-year screening interval for colonoscopy may not need to be shortened among people with high PRSs, but could potentially be prolonged for people with low and medium PRSs. Studies are needed to address personalized time intervals for repeat colonoscopies in average-risk screening cohorts.
Keywords: SNP; colorectal cancer; endoscopy; genetic variant.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
- Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.PMID: 23074514 Free PMC article.
- Long-term risk of colorectal cancer after negative colonoscopy.J Clin Oncol. 2011 Oct 1;29(28):3761-7. doi: 10.1200/JCO.2011.35.9307. Epub 2011 Aug 29.PMID: 21876077
- Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy.Gastroenterology. 2014 Mar;146(3):709-17. doi: 10.1053/j.gastro.2013.09.001. Epub 2013 Sep 5.PMID: 24012982
- Screening for Colorectal Cancer: An Updated Systematic Review [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Oct. Report No.: 08-05-05124-EF-1.PMID: 20722162 Free Books & Documents. Review.
- Screening for Colorectal Cancer: A Systematic Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jun. Report No.: 14-05203-EF-1.PMID: 27441328 Free Books & Documents. Review.
No hay comentarios:
Publicar un comentario